Re:The Villain of CRISPR
by biehl on Monday January 25, 2016 @01:03PM
(#10968713)
Exactly. An evaluation of the efficiency of "buying" clinical trials with patents would be very interesting.
[ Parent
| on HN ]
There are no comments on this comment yet.